Skip to content

NeoGenomics NEO Deferred Taxes

Deferred Taxes at other companies

GeneDx Holdings logo
GeneDx HoldingsWGS
$1.4M+21.8%
Opko Health logo
Opko HealthOPK
$114.56M-11.5%
CareDx logo
CareDxCDNA
$130K+0.8%
Veracyte logo
VeracyteVCYT
$636K-48.8%
TEC
Bio-TechneTECH
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B+86.5%
Enterprise value$1.6B+159%
P/S2.3×+0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's deferred taxes?
NeoGenomics (NEO) reported deferred taxes of $17.45M in Q1 2026.
How has NeoGenomics's deferred taxes changed year-over-year?
NeoGenomics's deferred taxes decreased by 16.8% year-over-year, from $20.97M to $17.45M.
What is the long-term trend for NeoGenomics's deferred taxes?
Over 5 years (2020 to 2025), NeoGenomics's deferred taxes has grown at a 27.5% compound annual growth rate (CAGR), from $5.42M to $18.22M.
What does deferred taxes mean?
This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.